Cargando…
Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019
The emergence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses a never before seen challenge to human health and the economy. Considering its clinical impact, with no streamlined therapeutic strategies in sight, it is crucial to understand the infection proces...
Autores principales: | Chakrabarty, Koushik, Shetty, Rohit, Argulwar, Shubham, Das, Debashish, Ghosh, Arkasubhra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437760/ https://www.ncbi.nlm.nih.gov/pubmed/34656419 http://dx.doi.org/10.1016/j.jcyt.2021.08.003 |
Ejemplares similares
-
Stem cell therapy in coronavirus disease 2019: current evidence and future potential
por: Shetty, Rohit, et al.
Publicado: (2021) -
Corneal cell therapy: with iPSCs, it is no more a far-sight
por: Chakrabarty, Koushik, et al.
Publicado: (2018) -
Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants
por: Vinekar, Anand, et al.
Publicado: (2021) -
Tear proteomics in dry eye disease
por: Kannan, Ramaraj, et al.
Publicado: (2023) -
Coronavirus disease 19 (COVID-19) and viral keratouveitis – unraveling the mystery
por: Sanjay, Srinivasan, et al.
Publicado: (2023)